Baseline levels of low-density lipoprotein cholesterol and lipoprotein (a) and the AvaII polymorphism of the low-density lipoprotein receptor gene influence the response of low-density lipoprotein cholesterol to pravastatin treatment - Lahoz, Carlos; Peña, Rocío; Mostaza, Jose M.; Laguna, Fernando; García-Iglesias, María F.; Taboada, Manuel; Pintó, Xavier (Metabolism, clinical and experimental, 2005)
Keywords: Adult; Aged; Cholesterol, LDL - blood; Deoxyribonucleases, Type II Site-Specific - metabolism; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use; Hypercholesterolemia - blood; Hypercholesterolemia - drug therapy; Hypercholesterolemia - genetics; Lipoprotein(a) - blood; Male; Middle Aged; Polymorphism, Genetic; Pravastatin - therapeutic use; Prospective Studies; Receptors, LDL - genetics